AmerisourceBergen (NYSE:ABC) updated its FY 2019 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $6.65-6.95 for the period, compared to the Thomson Reuters consensus estimate of $6.48. AmerisourceBergen also updated its FY19 guidance to $6.65-6.95 EPS.
Several equities analysts have issued reports on the company. Zacks Investment Research cut AmerisourceBergen from a hold rating to a sell rating in a research report on Wednesday, October 3rd. Robert W. Baird cut AmerisourceBergen from an outperform rating to a neutral rating in a research report on Friday, July 20th. ValuEngine cut AmerisourceBergen from a hold rating to a sell rating in a research report on Wednesday, September 12th. Mizuho reiterated a neutral rating on shares of AmerisourceBergen in a research report on Wednesday, September 19th. Finally, Royal Bank of Canada set a $90.00 target price on AmerisourceBergen and gave the stock a hold rating in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the company’s stock. AmerisourceBergen presently has an average rating of Hold and a consensus price target of $101.07.
Shares of ABC traded up $1.66 on Wednesday, reaching $85.66. The stock had a trading volume of 92,171 shares, compared to its average volume of 1,334,898. The stock has a market cap of $19.16 billion, a P/E ratio of 14.57, a P/E/G ratio of 1.26 and a beta of 0.97. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.94 and a quick ratio of 0.51. AmerisourceBergen has a twelve month low of $73.35 and a twelve month high of $106.27.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings results on Tuesday, November 6th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.44 by $0.01. The business had revenue of $43.30 billion for the quarter, compared to analysts’ expectations of $43.27 billion. AmerisourceBergen had a return on equity of 48.65% and a net margin of 0.69%. The company’s revenue was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.33 EPS. Research analysts expect that AmerisourceBergen will post 6.48 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, December 3rd. Investors of record on Monday, November 19th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.87%. This is a boost from AmerisourceBergen’s previous quarterly dividend of $0.38. AmerisourceBergen’s dividend payout ratio is currently 25.85%.
In other AmerisourceBergen news, Chairman Steven H. Collis sold 21,350 shares of the stock in a transaction on Monday, October 1st. The stock was sold at an average price of $93.09, for a total transaction of $1,987,471.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP John G. Chou sold 6,974 shares of the stock in a transaction on Wednesday, August 15th. The shares were sold at an average price of $83.94, for a total value of $585,397.56. Following the sale, the executive vice president now owns 56,126 shares in the company, valued at approximately $4,711,216.44. The disclosure for this sale can be found here. In the last quarter, insiders have sold 92,928 shares of company stock worth $8,332,406. 27.30% of the stock is owned by insiders.
TRADEMARK VIOLATION NOTICE: “AmerisourceBergen (ABC) Releases FY 2019 Earnings Guidance” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/11/07/amerisourcebergen-abc-releases-fy-2019-earnings-guidance.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
See Also: What is a Market Correction?
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.